WASHINGTON -- The FDA approved another thrombopoietin receptor agonist on Monday, for an indication not covered by other drugs intended to raise platelet counts. The new agent is avatrombopag ...

How Does Doptelet Work in Thrombocytopenia? Thrombocytopenia is when your blood has too few platelets (also called thrombocytes). Platelets are blood cells made in the soft, spongy tissue inside your ...

The US Food and Drug Administration (FDA) has approved avatrombopag (Doptelet, AkaRx Inc) to increase platelet counts in adults with thrombocytopenia and chronic liver disease who are to undergo a ...

Patients undergoing transcatheter aortic valve replacement (TAVR) have decreases in platelet counts that are typically transient, lasting just a few days. But in those with preexisting ...

Thrombocytopenia (low platelet count) is common in people with cirrhosis. It can be caused by many factors, including an enlarged spleen and decreased platelet production. Severe thrombocytopenia can ...

Platelet-rich plasma (PRP) treatment, which involves injecting a small amount of a patient's own blood to release various growth factors from platelets, continues to increase in popularity. The ...

In patients undergoing peripheral endovascular procedures, high on-treatment platelet reactivity is associated with a dramatic increase in risk of adverse clinical events, according to a study ...